The Valley Desk

ReviewFrontiers in immunologyPublished

Immunogenicity risk assessment for tailored mitigation and monitoring of biotherapeutics during development: recommendations from the European Immunogenicity Platform

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Review
Venue
Frontiers in immunology
Published
Subject terms
Humans; Biological Products; Risk Assessment; Europe; Drug Development; Immunogenicity; Bioanalysis; Biotherapeutics; Anti-drug Antibody; Immunogenicity Mitigation; Immunogenicity Monitoring; Immunogenicity Risk Assessment
PubMed ID
40475758
PubMed Central ID
PMC12138202
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal